信达生物获摩根大通增持约123.37万股 每股作价约78.7港元
Xin Lang Cai Jing·2026-02-07 04:50

Group 1 - Morgan Stanley increased its stake in Innovent Biologics (01801) by 1.233667 million shares at a price of 78.6975 HKD per share, totaling approximately 97.0865 million HKD [1][3] - After the increase, Morgan Stanley's total shareholding in Innovent Biologics is approximately 87.9149 million shares, representing a stake of 5.06% [1][3]